TAVI global registry delivers 1st results | MassDevice.com On Call

October 3, 2012 by MassDevice staff

Edwards Lifesciences' transcatheter aortic valve implantation system proves effective in the 1st reports from a global registry of valve-in-valve TAVI patients, but safety issues raise eyebrows.

Updated October 3, 2012, at 9:45 p.m. to correct the lead story.

MassDevice On Call

MASSDEVICE ON CALL — The 1st reports from a global registry evaluating Edwards Lifesciences' (NYSE:EW) Sapien transcatheter aortic valve implantation inside a failing valve or mitral ring came with mixed results.*

Get the complete picture with a MassDevice Plus membership. Registered users can login here.